Navigation Links
OHSU Oregon National Primate Research Center develops new, safer method for making vaccines
Date:5/29/2012

BEAVERTON, Ore. - While vaccines are perhaps medicine's most important success story, there is always room for improvement. Researchers at Oregon Health & Science University's Oregon National Primate Research Center (ONPRC) appear to have done just that. As explained in a newly published research paper, Mark Slifka, Ph.D., and colleagues have discovered a new method for creating vaccines that is thought to be safer and more effective than current approaches. The research results are published online in the journal Nature Medicine.

"Most vaccines have an outstanding safety record," explained Slifka. "It is important to keep in mind that no medical achievement has saved more lives than the simple act of vaccination. However, for many diseases, we have struggled to develop an effective vaccine. In other cases, vaccines may be protective, but come with rare but serious side effects. For instance, the live oral polio vaccine was very effective at stopping polio outbreaks and transmission, but was also responsible for eight to 10 cases of vaccine-associated polio in the United States each year. This problem was solved in 2000 when the U.S. switched to a formaldehyde-fixed 'dead' form of the vaccine. Our goal is to make vaccines like these safer and potentially even more effective by pioneering an entirely new approach to vaccine development."

Slifka's approach is remarkable because it is the first to demonstrate that hydrogen peroxide can inactivate viruses for use as vaccines. Although hydrogen peroxide has long been known as an effective antiseptic and is often used to sterilize medical equipment, it was believed that it would be too damaging to be useful in vaccine development. It turns out that this previous notion was incorrect. In fact, peroxide may turn out to be one of the best new approaches to future vaccine design.

In the study published this week, Slifka's lab generated not one, but three vaccines.

"We wanted to demonstrate that this is truly a platform technology and not just a one-hit-wonder," explained Slifka. "For this reason, we chose three unrelated model systems and demonstrated protective vaccine-induced immunity in all three cases."

The three diseases targeted by these viruses are West Nile virus, Lymphocytic choriomeningitis virus (a relative of lassa fever virus, known to cause hemorrhagic fever in Africa) and vaccinia virus (widely known for its previous use in the smallpox vaccine.)

An Oregon-based biotech company, Najt Technologies, Inc., is hoping that these advances in vaccine technology will result not only in new vaccines but also new jobs in the Portland area.

"This new approach really gives a boost to an area of vaccine development that's been stagnant for some time," said Ian Amanna, Ph.D., associate vice president for research at Najt Technologies.

"Because of these advances, we've been increasing our workforce and putting together a group of very talented researchers. In partnership with OHSU, we're excited to have the opportunity to further develop this technology into commercial vaccines that can offer protection for at-risk individuals. These vaccines will not only be important to international travelers, but also to the people living in endemic regions. These places are often in developing countries with limited resources for preparing and testing life-saving vaccines and we are looking forward to the day that we can bring these new vaccines to the countries that need them the most."

Najt Technologies, founded by Slifka and colleagues using methods first discovered at OHSU, hopes to continue working together with academic institutions such as OHSU, ONPRC, and Washington University-St. Louis to create new and better vaccines for some of the world's biggest problems including West Nile virus, yellow fever and dengue hemorrhagic fever.


'/>"/>

Contact: Jim Newman
newmanj@ohsu.edu
503-494-4158
Oregon Health & Science University
Source:Eurekalert

Related medicine news :

1. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
2. Study finds most Oregon hospices do not fully participate in the Death with Dignity Act
3. Relax for Hope May 23 - a Spa Day Fundraiser for the American Cancer Soiety's Relay for Life in Lincoln City, Oregon.
4. Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards
5. Despite much-higher poverty rates, rural Oregonians use less public assistance
6. State of Oregon Department of Human Services Selects Netsmart Technologies for Comprehensive Behavioral Healthcare Integration Project
7. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
8. Boston researcher, surgical oncologist receives national award
9. National initiative launched to change the way biology departments approach undergraduate education
10. Georgetown physician leads national resveratrol study for Alzheimers disease
11. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... OH (PRWEB) , ... July 24, 2017 , ... ... place August 13-17 in National Harbor, MD. This year's theme focuses on the ... the principal benchmarks for quality and integrity in testing and calibration will be ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... A Southern ... food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: A ... in her life and how she has risen above. , In “Memories,” readers get ...
(Date:7/24/2017)... Church, VA (PRWEB) , ... July 24, 2017 ... ... and Managers, **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – ... ends on Friday, July 28. , Increased FDA scrutiny and growing demands to ...
(Date:7/24/2017)... ... ... customizable and interactive Bible study guide for children. “The Perfect Gift” is the creation of ... accepted Christ as her Savior, yet never studied His word, surrendered to His will, or ... book to her children, so they would know the importance of the truth. She ...
(Date:7/24/2017)... ... 24, 2017 , ... The Center for Addiction Recovery Training ... host a second Multiple Pathways of Recovery Conference on October 23-26, 2017. This ... from CCAR’s foundational principle – a belief in multiple pathways of recovery, aims ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
Breaking Medicine Technology: